GCP
HARP

GSA Capital Partners’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

GSA Capital Partners’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10,914
Closed -$106K – 2012
2022
Q3 		$106K Buy
+10,914
New +$204K 0.01% 1355
2022
Q1 		– Sell
-3,527
Closed -$266K – 1945
2021
Q4 		$266K Buy
3,527
+1,043
+42% +$71.2K 0.03% 1029
2021
Q3 		$196K Buy
2,484
+718
+41% +$72.2K 0.02% 1247
2021
Q2 		$245K Sell
1,766
-657
-27% -$125K 0.03% 1074
2021
Q1 		$507K Sell
2,423
-5,944
-71% -$1.19M 0.08% 348
2020
Q4 		$1.39M Buy
8,367
+5,143
+160% +$795K 0.23% 68
2020
Q3 		$548K Buy
3,224
+2,069
+179% +$298K 0.09% 339
2020
Q2 		$192K Buy
+1,155
New +$180K 0.11% 364

Other funds holding HARP

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

GSA Capital Partners's HARP Position: Q4 2022 in Review

GSA Capital Partners sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q4 2022, closing a stake of 10,914 shares — an estimated $106K sold.

GSA Capital Partners first reported a position in HARP in Q2 2020 and held it in 8 quarters. The position peaked at $1.39M in Q4 2020. 49 funds tracked by Wall St. Rank hold HARP as of Q4 2022.

  • GSA Capital Partners reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • GSA Capital Partners sold 10,914 Harpoon Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $106K.
  • GSA Capital Partners first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q2 2020 and held it in 8 quarters.
  • GSA Capital Partners's Harpoon Therapeutics, Inc. Common Stock position peaked at $1.39M in Q4 2020.
  • 49 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q4 2022.

Based on GSA Capital Partners's 13F filing for Q4 2022, filed 13 Feb 2023.